COMBINED DETECTION OF CYCLIN D1,P27 AND DNA CONTENT IN ESOPHAGEAL CANCER

Objective： To investigate the expressions of cyclin D1 and p27 and DNA content in esophageal cancer and adjacent normal tissues, and to discuss the relationship between them. Methods： The cyclinD1 and p27 were detected by immunohistochernical staining; DNA content was measured by flow cytometry. Results： The positive expression rates of cyclinD1 and p27 in cancer were 45.8% and 33.3% respectively, the DNA content in the positive group of cyclinD1 was higher than that in the negative group of cyclinDl（1.54±0.21 versus 1.08i-0.43, P〈0.05）, while the DNA content and SPF （S-phase fraction） in the positive group of p27 were lower than those in the negative group （1.10±0.19 and 5.56%±5.18% versus 1.66±0.28 and 19.78%±6.12%, P〈0.05）. Conclusion： The data show that the expression of cyclinD1 and p27 are related to the ontogenesis and progression of esophageal cancer. The combined detection of cyclinD1, p27 and DNA content may be indicators of diagnosis and assessment of esophageal cancer.

Qufeng Tongluo Prescription(祛风通络方)Inhibits Mesangial Cell Proliferation and Promotes Apoptosis through Regulating Cell Cycle Progression

Objective： To study the effects and possible underlying mechanism of Qufeng Tongluo Prescription （祛风通络方, QFTL） on the regulation of mesangial cells （MCs） proliferation and apoptosis. Methods： The MCs used in this experiment have undergone five passages induced by lipopolysaccharide （LPS）. Changes in the proliferation, apoptosis, cell cycle regulatory proteins and mRNA expression levels of the MCs after administration of Benazepril or QFTL were measured by methyl thiazolyl tetrazolium （MTT） reduction assay, flow cytometry, Western blot and quantitative real-time polymerase chain reaction （qRT-PCR）, respectively. Results： The addition of Benazepril or QFTL serum inhibited LPS-induced MC proliferation after treatment for 24, 48 and 72 h, respectively （P〈0.05 or P〈0.01）. Moreover, the inhibitory effect is more significant in the QFTL group at 48 h （P〈0.05）. Compared with the control group, LPS-induced cell proliferation decreased the number of cells in G1 phase versus cells in S and G2/M phases, while the addition of QFTL and Benazepril serum increased the ratio of cells at G1 phase （P〈0.05 or P〈0.01） to cells at S phase （P〈0.01）, implicating the cell cycle inhibition effect exerted by QFTL. LPS decreased the level of MC apoptosis, compared with the control group （P〈0.05）, while QFTL and Benazepril serum increased the level of MC apoptosis （P〈0.01）. Moreover, the difference between the QFTL group and the Benazepril group was statistically significant （P〈0.01）. Compared with the control group, the protein and mRNA expression levels of cylinD1, cyclin dependent kinase 2 （CDK2） and p21 were significantly increased （P〈0.05 or P〈0.01）, p27 was decreased but with no statistical significance （P〉0.05）; After being treated with QFTL and Benazepril serum, the protein and mRNA expression levels of cylinD1, CDK2, p21 were decreased and p27 increased significantly （P〈0.05 or P〈0.01）; Compared with the Benazepril group, QFTL show better effects on protein and mRNA expression levels of cylinD1, CDK2 （P〈0.05 or P〈0.01） and p21 protein expression （P〈0.05）. Conclusion： QFTL inhibits MCs proliferation, promotes MCs apoptosis through an underlying mechanism of down-regulating the protein and mRNA expression levels of cylinD1, CDK2, p21 and up-regulation of the expression level of p27.